Loading…

Change in admission blood glucose from chronic glycemic status in acute heart failure hospitalization and 30-day outcomes: A retrospective analysis

Admission blood glucose (BG) has demonstrated contradictory association with 30-day mortality in acute heart failure (AHF) hospitalization. To explore these contradictory findings, we aimed to determine if admission BG reflects an acute change from chronic glucose control and investigate the associa...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2020-01, Vol.299, p.180-185
Main Authors: Cox, Zachary L., Lai, Pikki, Lewis, Connie M., Lindenfeld, JoAnn
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Admission blood glucose (BG) has demonstrated contradictory association with 30-day mortality in acute heart failure (AHF) hospitalization. To explore these contradictory findings, we aimed to determine if admission BG reflects an acute change from chronic glucose control and investigate the association between the admission and chronic BG change (ΔBG) with 30-day mortality in AHF. We analyzed patients (n = 1045) age ≥ 65 with Centers of Medicare Services benefits and known 30-day all-cause mortality hospitalized with AHF at an academic medical center from 2009 to 2016. We included diabetic (n = 736) and non-diabetic (n = 309) patients with recent Hemoglobin A1c (HbA1c). We defined ΔBG as the difference in the admission and chronic BG, calculated from HbA1c. Admission BG was 126 (101, 167) mg/dl and was moderately elevated (≥170 mg/dl) in 25% of admissions. The median (IQR) ΔBG was −7 (−29, 26) mg/dl, with 74% of all admissions (66% diabetic, 92% non-diabetic) presenting within ±50 mg/dl of the chronic BG. Admission BG was not associated with mortality. ΔBG > +100 mg/dl displayed increased 30-day mortality (18.6% vs 6.9%, p 200 mg/dl (n = 166), a ΔBG > +100 mg/dl was present in 77% of those deceased vs 31% of those alive at 30 days (p = 0.003; positive likelihood ratio = 5.7). ΔBG > +100 mg/dl was strongly associated with 30-day mortality risk (OR 6.4, 95% CI 2.3–18.9; p = 0.0005) after multivariate adjustment. Admission BG predominantly reflects chronic glycemic status. Increased change in admission from chronic BG was associated with increased 30-day mortality. •Elevated blood glucose at AHF hospital admission reflects chronic hyperglycemia.•Change from chronic glucose values further identifies a high-risk cohort.•Admission hyperglycemia should be interpreted in context of chronic glucoses.
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2019.07.069